{"product_id":"test-urinaire-a-tremper-13-drogues","title":"Teste Urinário 13 Drogas Drugdiag® 13T - Novas Drogas de síntese","description":"\u003cstyle\u003e\n\/* =========================================================\n   AMA Prévention — B-SAFE\n   Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n   Sans JS — prêt Shopify\n   ========================================================= *\/\n\n.ama-bsafe-2026 {\n  --ama-blue: #004C96;\n  --ama-blue-deep: #003B78;\n  --ama-blue-night: #00325f;\n  --ama-orange: #FE4B09;\n  --ama-text: #004C96;\n  --ama-muted: #667085;\n  --ama-border: #dbe6f2;\n  --ama-soft: #f6f9fd;\n  --ama-white: #ffffff;\n\n  width: 100%;\n  max-width: 1180px;\n  margin: 0 auto;\n  padding: 0;\n  font-family: inherit;\n  color: var(--ama-text);\n  background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n  box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n  min-width: 0;\n}\n\n.ama-bsafe-panel {\n  width: 100%;\n  position: relative;\n  overflow: hidden;\n  isolation: isolate;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 28px;\n  background:\n    radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n    radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n    linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n  box-shadow:\n    0 22px 55px rgba(0, 76, 150, 0.10),\n    inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n  width: 100%;\n  padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n  margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n  display: inline-flex;\n  align-items: center;\n  gap: 8px;\n  margin-bottom: 14px;\n  padding: 7px 12px;\n  border-radius: 999px;\n  background: rgba(0, 76, 150, 0.08);\n  color: var(--ama-blue);\n  font-size: 12px;\n  font-weight: 900;\n  letter-spacing: 0.04em;\n  text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n  content: \"\";\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n  margin: 0 0 16px;\n  color: var(--ama-blue);\n  font-size: clamp(30px, 4vw, 46px);\n  line-height: 1.08;\n  font-weight: 900;\n  letter-spacing: -0.045em;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n  margin: 0 0 16px;\n  color: var(--ama-text);\n  font-size: clamp(16px, 1.4vw, 18px);\n  line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n  color: var(--ama-blue);\n  font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n  display: flex;\n  flex-wrap: wrap;\n  gap: 10px;\n  margin-top: 26px;\n  padding: 14px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 20px;\n  background: rgba(255, 255, 255, 0.72);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n  display: inline-flex;\n  align-items: center;\n  gap: 8px;\n  flex: 1 1 230px;\n  padding: 10px 12px;\n  border-radius: 999px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  border: 1px solid rgba(0, 76, 150, 0.10);\n  color: var(--ama-blue);\n  font-size: 14px;\n  font-weight: 850;\n  line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n  content: \"\";\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n  flex-shrink: 0;\n}\n\n\/* =========================================================\n   Accordéon principal\n   Fermé : bleu nuit\n   Ouvert : clair + contenu dans le même bloc\n   ========================================================= *\/\n\n.ama-bsafe-accordion {\n  width: 100%;\n  max-width: 920px;\n  margin: 0 auto;\n  display: grid;\n  gap: 12px;\n}\n\n.ama-bsafe-item {\n  border-radius: 24px;\n  overflow: hidden;\n  background:\n    linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n  border: 1px solid rgba(0, 76, 150, 0.26);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.22),\n    inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n    0 16px 36px rgba(0, 76, 150, 0.17);\n  transition:\n    background 220ms ease,\n    box-shadow 220ms ease,\n    border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n  background:\n    radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n    linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n  border-color: rgba(0, 76, 150, 0.14);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.98),\n    0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n  position: relative;\n  min-height: 66px;\n  padding: 14px 58px 14px 18px;\n  display: flex;\n  align-items: center;\n  cursor: pointer;\n  list-style: none;\n  user-select: none;\n  -webkit-tap-highlight-color: transparent;\n  color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n  display: none;\n}\n\n.ama-bsafe-item[open] summary {\n  color: var(--ama-blue);\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n  border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n  content: \"+\";\n  position: absolute;\n  right: 16px;\n  top: 50%;\n  width: 36px;\n  height: 36px;\n  transform: translateY(-50%);\n  border-radius: 999px;\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  color: #ffffff;\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n  border: 1px solid rgba(255, 255, 255, 0.26);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.30),\n    0 10px 22px rgba(0, 0, 0, 0.14);\n  font-size: 22px;\n  font-weight: 760;\n  line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n  content: \"−\";\n  color: var(--ama-blue);\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n  border-color: rgba(0, 76, 150, 0.10);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.96),\n    0 8px 18px rgba(0, 76, 150, 0.10);\n  font-size: 24px;\n  font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n  .ama-bsafe-item:not([open]):hover {\n    box-shadow:\n      inset 0 1px 0 rgba(255, 255, 255, 0.26),\n      inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n      0 20px 44px rgba(0, 76, 150, 0.22);\n  }\n\n  .ama-bsafe-item[open]:hover {\n    box-shadow:\n      inset 0 1px 0 rgba(255, 255, 255, 0.98),\n      0 18px 42px rgba(0, 76, 150, 0.13);\n  }\n}\n\n.ama-bsafe-acc-title {\n  display: block;\n  font-size: 16px;\n  line-height: 1.18;\n  font-weight: 800;\n  letter-spacing: -0.018em;\n  color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n  display: block;\n  margin-top: 3px;\n  font-size: 13px;\n  line-height: 1.24;\n  font-weight: 650;\n  letter-spacing: -0.01em;\n  color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n  color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n  padding: clamp(20px, 4vw, 34px);\n  background: transparent;\n  animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n  from {\n    opacity: 0;\n    transform: translateY(5px);\n  }\n\n  to {\n    opacity: 1;\n    transform: translateY(0);\n  }\n}\n\n\/* =========================================================\n   Contenu\n   ========================================================= *\/\n\n.ama-bsafe-content h2 {\n  margin: 0 0 18px;\n  color: var(--ama-blue);\n  font-size: clamp(24px, 3vw, 36px);\n  line-height: 1.10;\n  font-weight: 900;\n  letter-spacing: -0.04em;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n  content: \"\";\n  display: block;\n  width: 78px;\n  height: 4px;\n  margin-top: 14px;\n  border-radius: 999px;\n  background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n  margin: 0 0 10px;\n  color: var(--ama-blue);\n  font-size: clamp(18px, 1.7vw, 23px);\n  line-height: 1.18;\n  font-weight: 900;\n  letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n  margin: 0 0 18px;\n  color: var(--ama-text);\n  font-size: 16px;\n  line-height: 1.72;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n  display: grid;\n  grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n  gap: 18px;\n  margin: 26px 0;\n}\n\n.ama-bsafe-card {\n  position: relative;\n  min-height: 150px;\n  padding: 24px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 22px;\n  background: rgba(255, 255, 255, 0.86);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  overflow-wrap: break-word;\n  transition:\n    transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n  margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n  .ama-bsafe-card:hover,\n  .ama-bsafe-substance-row:hover {\n    transform: translateY(-2px);\n    border-color: rgba(254, 75, 9, 0.32);\n    background: #ffffff;\n    box-shadow:\n      0 16px 34px rgba(0, 76, 150, 0.10),\n      inset 0 1px 0 rgba(255, 255, 255, 0.95);\n  }\n}\n\n.ama-bsafe-substance-list {\n  display: grid;\n  gap: 12px;\n  margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n  width: 100%;\n  display: flex;\n  align-items: center;\n  flex-wrap: wrap;\n  gap: 12px 18px;\n  padding: 16px 18px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 20px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  transition:\n    transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  flex: 0 0 130px;\n  width: 130px;\n  min-width: 130px;\n  max-width: 130px;\n  min-height: 38px;\n  padding: 7px 14px;\n  border-radius: 999px;\n  background: rgba(0, 76, 150, 0.08);\n  color: var(--ama-blue);\n  font-size: 15px;\n  font-weight: 950;\n  letter-spacing: -0.01em;\n  text-align: center;\n}\n\n.ama-bsafe-substance-main {\n  flex: 1 1 420px;\n  min-width: min(100%, 320px);\n  color: var(--ama-text);\n  font-size: 15px;\n  line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  flex: 0 0 auto;\n  margin-left: auto;\n  min-height: 34px;\n  padding: 6px 12px;\n  border-radius: 999px;\n  background: rgba(254, 75, 9, 0.08);\n  color: var(--ama-orange);\n  font-size: 13px;\n  font-weight: 900;\n  white-space: nowrap;\n}\n\n.ama-bsafe-list {\n  list-style: none;\n  padding: 0;\n  margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n  position: relative;\n  padding: 15px 18px 15px 44px;\n  margin-bottom: 10px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 18px;\n  background: rgba(255, 255, 255, 0.84);\n  box-shadow:\n    0 6px 18px rgba(0, 76, 150, 0.035),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  color: var(--ama-text);\n  font-size: 15px;\n  line-height: 1.62;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n  content: \"\";\n  position: absolute;\n  left: 18px;\n  top: 22px;\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n  margin: 22px 0;\n  padding: 18px 20px;\n  border: 1px solid rgba(0, 76, 150, 0.10);\n  border-radius: 18px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  color: var(--ama-muted);\n  font-size: 14px;\n  line-height: 1.62;\n  font-style: italic;\n  box-shadow:\n    0 8px 20px rgba(0, 76, 150, 0.04),\n    inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n  margin: 28px 0;\n  padding: 24px;\n  border-radius: 22px;\n  background:\n    radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n    linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n  box-shadow:\n    0 16px 34px rgba(254, 75, 9, 0.22),\n    inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n  color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n  margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n  margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n  display: grid;\n  gap: 12px;\n  margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 18px;\n  background: rgba(255, 255, 255, 0.86);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n  cursor: pointer;\n  padding: 18px 50px 18px 18px;\n  color: var(--ama-blue);\n  font-weight: 900;\n  line-height: 1.35;\n  list-style: none;\n  position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n  display: none;\n}\n\n.ama-bsafe-faq summary::after {\n  content: \"+\";\n  position: absolute;\n  right: 18px;\n  top: 50%;\n  transform: translateY(-50%);\n  color: var(--ama-orange);\n  font-size: 24px;\n  line-height: 1;\n  font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n  content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n  padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n  margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n  margin-top: 30px;\n  padding: 24px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 24px;\n  background:\n    radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n    linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  box-shadow:\n    0 14px 34px rgba(0, 76, 150, 0.08),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n  margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  min-height: 46px;\n  padding: 12px 22px;\n  border-radius: 999px;\n  background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n  color: #ffffff !important;\n  font-weight: 900;\n  text-decoration: none;\n  box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n  margin-top: 30px;\n  padding-top: 22px;\n  border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n  margin: 0;\n  color: var(--ama-muted);\n  font-size: 13px;\n  line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n  max-width: 1180px;\n  margin: 32px auto 0;\n  padding: 24px;\n  border: 1px solid rgba(0, 76, 150, 0.18);\n  border-radius: 22px;\n  background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n  box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n  color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n  margin: 0 0 8px;\n  font-size: 13px;\n  letter-spacing: 0.08em;\n  text-transform: uppercase;\n  font-weight: 900;\n  color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n  margin: 0 0 12px;\n  color: #004c96;\n  font-size: clamp(22px, 2.4vw, 30px);\n  line-height: 1.15;\n  font-weight: 900;\n  letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n  margin: 0 0 10px;\n  line-height: 1.65;\n  color: #184b78;\n  font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n  margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n  .ama-bsafe-grid {\n    grid-template-columns: repeat(2, minmax(0, 1fr));\n  }\n\n  .ama-bsafe-substance-row {\n    display: grid;\n    grid-template-columns: 130px minmax(0, 1fr);\n    align-items: start;\n    gap: 10px 14px;\n  }\n\n  .ama-bsafe-substance-code {\n    grid-column: 1;\n    grid-row: 1;\n  }\n\n  .ama-bsafe-substance-threshold {\n    grid-column: 2;\n    grid-row: 1;\n    justify-self: start;\n    margin-left: 0;\n  }\n\n  .ama-bsafe-substance-main {\n    grid-column: 1 \/ -1;\n    grid-row: 2;\n    min-width: 0;\n    width: 100%;\n  }\n}\n\n@media (max-width: 640px) {\n  .ama-bsafe-panel {\n    border-radius: 22px;\n  }\n\n  .ama-bsafe-inner {\n    padding: 24px 14px;\n  }\n\n  .ama-bsafe-title {\n    font-size: clamp(28px, 8.4vw, 36px);\n    letter-spacing: -0.035em;\n  }\n\n  .ama-bsafe-summary-strip {\n    display: grid;\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-summary-item {\n    border-radius: 16px;\n  }\n\n  .ama-bsafe-accordion {\n    gap: 10px;\n  }\n\n  .ama-bsafe-item {\n    border-radius: 20px;\n  }\n\n  .ama-bsafe-item summary {\n    min-height: 60px;\n    padding: 12px 52px 12px 15px;\n  }\n\n  .ama-bsafe-item summary::after {\n    right: 14px;\n    width: 32px;\n    height: 32px;\n    font-size: 20px;\n  }\n\n  .ama-bsafe-item[open] summary::after {\n    font-size: 22px;\n  }\n\n  .ama-bsafe-acc-title {\n    font-size: 15px;\n    line-height: 1.18;\n    letter-spacing: -0.014em;\n  }\n\n  .ama-bsafe-acc-sub {\n    font-size: 12.2px;\n    line-height: 1.22;\n  }\n\n  .ama-bsafe-content {\n    padding: 20px 15px;\n  }\n\n  .ama-bsafe-content h2 {\n    font-size: clamp(24px, 7vw, 30px);\n  }\n\n  .ama-bsafe-grid {\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-card {\n    padding: 20px;\n  }\n\n  .ama-bsafe-substance-row {\n    padding: 16px;\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-substance-code {\n    width: fit-content;\n    min-width: 0;\n    max-width: 100%;\n  }\n\n  .ama-bsafe-substance-threshold {\n    grid-column: 1;\n    grid-row: auto;\n  }\n\n  .ama-bsafe-validation {\n    padding: 20px;\n    border-radius: 20px;\n  }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Test Urinaire 13 Drogues Drugdiag® 13T\"\u003e\n  \u003cdiv class=\"ama-bsafe-panel\"\u003e\n    \u003cdiv class=\"ama-bsafe-inner\"\u003e\n      \u003cheader class=\"ama-bsafe-header\"\u003e\n        \u003cspan class=\"ama-bsafe-kicker\"\u003eTeste urinário profissional\u003c\/span\u003e\n        \u003ch2 class=\"ama-bsafe-title\"\u003eTeste Urinário 13 Drogas Drugdiag® 13T\u003c\/h2\u003e\n        \u003cdiv class=\"ama-bsafe-lead\"\u003e\n          \u003cp style=\"font-size: 17px; line-height: 1.8; margin-bottom: 15px;\"\u003e\n        O \u003cstrong\u003eteste urinário Drugdiag® T13\u003c\/strong\u003e é um dispositivo de rastreio multi-drogas que permite pesquisar simultaneamente \u003cstrong\u003e13 famílias de substâncias\u003c\/strong\u003e na urina. Foi concebido para profissionais de saúde, empresas, estruturas de prevenção e particulares que queiram realizar um controlo rápido, fiável e fácil de interpretar.\n      \u003c\/p\u003e\n\n      \u003cp style=\"font-size: 16px; line-height: 1.7; margin: 0;\"\u003e\n        Este teste não deteta drogas sintéticas do tipo 3-MMC, 4-MMC, 2-MMC, PTC \/ Buddha Blue, MDPV ou α-PVP. O Drugdiag® T13 foca-se precisamente nas seguintes famílias: \u003cstrong\u003eTHC, AMP, BAR, BZO, BUP, COC, MDMA, MET, MTD, MOP, TCA, TML e FYL\u003c\/strong\u003e.\n      \u003c\/p\u003e\n\n      \u003ch3 style=\"color: #004C96;\"\u003e🧪 Substâncias detetadas pelo Drugdiag® T13:\u003c\/h3\u003e\n      \u003cul\u003e\n        \u003cli\u003e\n\u003cstrong\u003eTHC:\u003c\/strong\u003e cannabis \/ THC-COOH.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eAMP:\u003c\/strong\u003e anfetaminas.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eBAR:\u003c\/strong\u003e barbitúricos.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eBZO:\u003c\/strong\u003e benzodiazepinas.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eBUP:\u003c\/strong\u003e buprenorfina.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eCOC:\u003c\/strong\u003e cocaína.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eMDMA:\u003c\/strong\u003e ecstasy.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eMET:\u003c\/strong\u003e metanfetaminas.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eMTD:\u003c\/strong\u003e metadona.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eMOP:\u003c\/strong\u003e opiáceos \/ morfina.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eTCA:\u003c\/strong\u003e antidepressivos tricíclicos.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eTML:\u003c\/strong\u003e tramadol.\u003c\/li\u003e\n        \u003cli\u003e\n\u003cstrong\u003eFYL:\u003c\/strong\u003e fentanil.\u003c\/li\u003e\n      \u003c\/ul\u003e\n        \u003c\/div\u003e\n      \u003c\/header\u003e\n      \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n        \u003cdetails class=\"ama-bsafe-item\" open\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003ePor que escolher o teste urinário Drugdiag® T13?\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003ePor que escolher o teste urinário Drugdiag® T13? Rastreio amplo numa única análise…\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003ePor que escolher o teste urinário Drugdiag® T13?\u003c\/h2\u003e\n\u003cdiv class=\"ama-bsafe-grid\"\u003e\n      \u003cdiv class=\"ama-bsafe-card\"\u003e\n        \u003ch3 style=\"margin-top: 0;\"\u003eRastreio amplo numa única análise\u003c\/h3\u003e\n        \u003cp style=\"margin-bottom: 0;\"\u003e\n          O Drugdiag® T13 permite controlar 13 famílias de substâncias com um único dispositivo. É especialmente útil quando é necessário um rastreio urinário completo, nomeadamente em contextos profissionais, médicos, preventivos ou pessoais.\n        \u003c\/p\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv class=\"ama-bsafe-card\"\u003e\n        \u003ch3 style=\"margin-top: 0;\"\u003eLeitura rápida e simples\u003c\/h3\u003e\n        \u003cp style=\"margin-bottom: 10px;\"\u003e\n          O teste foi concebido para uma utilização prática: recolha de urina, contacto com a amostra, seguida de leitura visual do resultado em poucos minutos conforme as indicações do folheto.\n        \u003c\/p\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv class=\"ama-bsafe-card\"\u003e\n        \u003ch3 style=\"margin-top: 0;\"\u003eSolução profissional\u003c\/h3\u003e\n        \u003cp style=\"margin-bottom: 0;\"\u003e\n          Adaptado a empresas, profissionais de saúde, estruturas de prevenção e particulares, este teste oferece uma solução fiável para identificar rapidamente a presença possível de substâncias frequentemente pesquisadas.\n        \u003c\/p\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eOs pontos fortes do Drugdiag® T13\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eOs pontos fortes do Drugdiag® T13 13 famílias pesquisadas: THC, AMP, BAR, BZO, BUP,…\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eOs pontos fortes do Drugdiag® T13\u003c\/h2\u003e\n\u003cul\u003e\n      \u003cli\u003e\n\u003cstrong\u003e13 famílias pesquisadas:\u003c\/strong\u003e THC, AMP, BAR, BZO, BUP, COC, MDMA, MET, MTD, MOP, TCA, TML e FYL.\u003c\/li\u003e\n      \u003cli\u003e\n\u003cstrong\u003eFormato urinário:\u003c\/strong\u003e adaptado à deteção de numerosos metabólitos eliminados na urina.\u003c\/li\u003e\n      \u003cli\u003e\n\u003cstrong\u003eResultado rápido:\u003c\/strong\u003e leitura visual em poucos minutos conforme o protocolo de utilização.\u003c\/li\u003e\n      \u003cli\u003e\n\u003cstrong\u003eUso versátil:\u003c\/strong\u003e empresas, saúde, prevenção, coletividades, estruturas especializadas e auto-controle.\u003c\/li\u003e\n      \u003cli\u003e\n\u003cstrong\u003eFabricação francesa:\u003c\/strong\u003e dispositivo da gama Drugdiag® do laboratório Toda Pharma.\u003c\/li\u003e\n      \u003cli\u003e\n\u003cstrong\u003eQualidade profissional:\u003c\/strong\u003e dispositivo médico de diagnóstico in vitro com marcação CE.\u003c\/li\u003e\n    \u003c\/ul\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eTabela das 13 famílias detetadas\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eTabela das 13 famílias detetadas O Drugdiag® T13 não deve ser confundido com um…\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eTabela das 13 famílias detetadas\u003c\/h2\u003e\n\u003cp\u003e\n      O Drugdiag® T13 não deve ser confundido com um teste específico para novas drogas sintéticas. Pesquisa as seguintes famílias de substâncias:\n    \u003c\/p\u003e\n\n    \u003ctable style=\"width: 100%;\" class=\"ama-bsafe-table\"\u003e\n      \u003cthead\u003e\n        \u003ctr\u003e\n          \u003cth style=\"width: 25%;\"\u003eCódigo\u003c\/th\u003e\n          \u003cth style=\"width: 35%;\"\u003eFamília detetada\u003c\/th\u003e\n          \u003cth style=\"width: 40%;\"\u003eExemplos \/ uso da deteção\u003c\/th\u003e\n        \u003c\/tr\u003e\n      \u003c\/thead\u003e\n      \u003ctbody\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eTHC\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eCannabis\u003c\/td\u003e\n          \u003ctd\u003ePesquisa de THC-COOH, principal metabólito da cannabis na urina.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eAMP\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eAnfetaminas\u003c\/td\u003e\n          \u003ctd\u003eDeteção de anfetaminas e substâncias relacionadas conforme os limiares do teste.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eBAR\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eBarbitúricos\u003c\/td\u003e\n          \u003ctd\u003ePesquisa de barbitúricos, substâncias sedativas hoje menos comuns mas ainda monitorizadas.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eBZO\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eBenzodiazepinas\u003c\/td\u003e\n          \u003ctd\u003eFamília de medicamentos ansiolíticos, hipnóticos ou sedativos que podem alterar a vigilância.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eBUP\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eBuprenorfina\u003c\/td\u003e\n          \u003ctd\u003ePesquisa de buprenorfina, especialmente no âmbito do acompanhamento ou controlo de substâncias opioides.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eCOC\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eCocaína\u003c\/td\u003e\n          \u003ctd\u003eDeteção de cocaína e seus metabólitos urinários.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eMDMA\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eEcstasy\u003c\/td\u003e\n          \u003ctd\u003ePesquisa de MDMA, substância estimulante frequentemente associada ao ambiente festivo.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eMET\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eMetanfetaminas\u003c\/td\u003e\n          \u003ctd\u003eDeteção de metanfetaminas conforme os limiares previstos pelo dispositivo.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eMTD\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eMetadona\u003c\/td\u003e\n          \u003ctd\u003ePesquisa de metadona, especialmente em contextos de acompanhamento ou controlo de opioides.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eMOP\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eOpiáceos \/ morfina\u003c\/td\u003e\n          \u003ctd\u003eDeteção de opiáceos naturais e relacionados, conforme o desempenho do teste.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eTCA\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eAntidepressivos tricíclicos\u003c\/td\u003e\n          \u003ctd\u003ePesquisa de TCA, família de medicamentos que pode ser monitorizada em certos contextos clínicos.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eTML\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eTramadol\u003c\/td\u003e\n          \u003ctd\u003eDeteção de tramadol, analgésico opioide que pode alterar a vigilância e apresentar riscos de uso indevido.\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003e\u003cstrong\u003eFYL\u003c\/strong\u003e\u003c\/td\u003e\n          \u003ctd\u003eFentanyl\u003c\/td\u003e\n          \u003ctd\u003ePesquisa de fentanyl, opioide potente que requer vigilância especial em contextos de prevenção e saúde.\u003c\/td\u003e\n        \u003c\/tr\u003e\n      \u003c\/tbody\u003e\n    \u003c\/table\u003e\n\n    \u003cp class=\"ama-bsafe-note\"\u003e\n      As famílias detetadas devem ser sempre verificadas com o folheto do produto e os limiares indicados pelo fabricante. Um teste rápido fornece um resultado orientativo; em caso de dúvida, o resultado deve ser confirmado por uma análise laboratorial.\n    \u003c\/p\u003e\n\n    \u003cdiv class=\"ama-bsafe-alert\"\u003e\n      \u003ch3\u003e⚠️ Importante: este teste não deteta drogas sintéticas específicas\u003c\/h3\u003e\n      \u003cp\u003e\n        O Drugdiag® T13 não deve ser apresentado como um teste de deteção de catinonas sintéticas ou canabinoides sintéticos.\n      \u003c\/p\u003e\n      \u003cp\u003e\n        Não é direcionado especificamente para substâncias como a \u003cstrong\u003e3-MMC\u003c\/strong\u003e, a \u003cstrong\u003e4-MMC\u003c\/strong\u003e, a \u003cstrong\u003e2-MMC\u003c\/strong\u003e, o \u003cstrong\u003ePTC \/ Buddha Blue\u003c\/strong\u003e, o \u003cstrong\u003eMDPV\u003c\/strong\u003e ou o \u003cstrong\u003eα-PVP\u003c\/strong\u003e.\n      \u003c\/p\u003e\n      \u003cp\u003e\n        Para pesquisar estas substâncias, é necessário usar um teste adaptado às novas substâncias psicoativas e às drogas sintéticas.\n      \u003c\/p\u003e\n    \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eEm que casos utilizar o Drugdiag® T13?\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eEm que casos utilizar o Drugdiag® T13? Empresas e prevenção O teste pode ser…\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eEm que casos utilizar o Drugdiag® T13?\u003c\/h2\u003e\n\u003cdiv class=\"ama-bsafe-grid\"\u003e\n      \u003cdiv class=\"ama-bsafe-card\"\u003e\n        \u003ch3 style=\"margin-top: 0;\"\u003eEmpresas e prevenção\u003c\/h3\u003e\n        \u003cp style=\"margin-bottom: 0;\"\u003e\n          O teste pode ser integrado numa abordagem de prevenção de riscos nas empresas, especialmente para postos de segurança ou ambientes sensíveis, respeitando o quadro legal aplicável, o regulamento interno e a confidencialidade dos resultados.\n        \u003c\/p\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv class=\"ama-bsafe-card\"\u003e\n        \u003ch3 style=\"margin-top: 0;\"\u003eProfissionais de saúde\u003c\/h3\u003e\n        \u003cp style=\"margin-bottom: 0;\"\u003e\n          Constitui uma ferramenta de deteção rápida para orientar um acompanhamento, um seguimento ou um pedido de confirmação biológica quando o contexto clínico o exigir.\n        \u003c\/p\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv class=\"ama-bsafe-card\"\u003e\n        \u003ch3 style=\"margin-top: 0;\"\u003eParticulares e auto-controle\u003c\/h3\u003e\n        \u003cp style=\"margin-bottom: 0;\"\u003e\n          O Drugdiag® T13 pode ser utilizado por particulares que desejem realizar um auto-controle urinário amplo, com uma leitura simples e rápida do resultado.\n        \u003c\/p\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eDeteção, prevenção e submissão química\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eDeteção, prevenção e submissão química O Drugdiag® T13 pode contribuir para uma…\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eDeteção, prevenção e submissão química\u003c\/h2\u003e\n\u003cp\u003e\n      O Drugdiag® T13 pode contribuir para uma abordagem de prevenção ampla, especialmente quando é necessário pesquisar várias famílias de substâncias como benzodiazepinas, opiáceos, tramadol, fentanil, metadona, cocaína, anfetaminas ou cannabis.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      No entanto, não permite a deteção de todas as substâncias que possam estar envolvidas numa situação de submissão química. Não substitui um acompanhamento médico, uma apresentação de queixa nem uma análise toxicológica especializada realizada por um laboratório.\n    \u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eConteúdo do saco\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eConteúdo do saco O produto está embalado para garantir uma utilização simples e…\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eConteúdo do saco\u003c\/h2\u003e\n\u003cp\u003e\n      O produto está embalado para garantir uma utilização simples e higiénica:\n    \u003c\/p\u003e\n\n    \u003cul\u003e\n      \u003cli\u003e1 teste urinário Drugdiag® T13.\u003c\/li\u003e\n      \u003cli\u003e1 instruções de utilização conforme a embalagem do fabricante.\u003c\/li\u003e\n      \u003cli\u003eResultado legível diretamente no dispositivo após a realização do teste.\u003c\/li\u003e\n    \u003c\/ul\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eEspecialização clínica \u0026amp; qualidade do dispositivo\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eEspecialização clínica \u0026amp; qualidade do dispositivo Tecnologia de rastreio rápido O Drugdiag®…\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eEspecialização clínica \u0026amp; qualidade do dispositivo\u003c\/h2\u003e\n\u003ch3\u003eTecnologia de rastreio rápido\u003c\/h3\u003e\n    \u003cp\u003e\n      O Drugdiag® T13 baseia-se numa tecnologia imunocromatográfica que permite pesquisar rapidamente a presença possível de várias famílias de substâncias numa amostra urinária.\n    \u003c\/p\u003e\n\n    \u003ch3\u003eDispositivo médico de diagnóstico in vitro\u003c\/h3\u003e\n    \u003cp\u003e\n      Este teste é um dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e. Possui a marcação \u003cstrong\u003eCE\u003c\/strong\u003e ao abrigo da regulamentação aplicável aos dispositivos de diagnóstico.\n    \u003c\/p\u003e\n\n    \u003ch3\u003eFabricação francesa e qualidade Toda Pharma\u003c\/h3\u003e\n    \u003cp\u003e\n      O Drugdiag® T13 pertence à gama Drugdiag® do laboratório francês \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, um ator reconhecido no teste de diagnóstico rápido. Insere-se numa exigência de qualidade profissional adaptada aos usos de rastreio, prevenção e saúde.\n    \u003c\/p\u003e\n\n    \u003cdiv class=\"certifications\"\u003e\n      \u003cspan class=\"cert-badge\"\u003eCE\u003c\/span\u003e\n      \u003cspan class=\"cert-badge\"\u003eDiagnóstico in vitro\u003c\/span\u003e\n      \u003cspan class=\"cert-badge\"\u003eToda Pharma\u003c\/span\u003e\n      \u003cspan class=\"cert-badge\"\u003eFabricação francesa\u003c\/span\u003e\n      \u003cspan class=\"cert-badge\"\u003eUso profissional\u003c\/span\u003e\n    \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eConselhos de utilização\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eConselhos de utilização Leia atentamente as instruções antes de usar. Utilize um…\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eConselhos de utilização\u003c\/h2\u003e\n\u003cul\u003e\n      \u003cli\u003eLeia atentamente as instruções antes de usar.\u003c\/li\u003e\n      \u003cli\u003eUtilize uma amostra urinária limpa, em condições adequadas.\u003c\/li\u003e\n      \u003cli\u003eRespeite o tempo de leitura indicado pelo fabricante.\u003c\/li\u003e\n      \u003cli\u003eNão interprete o resultado para além do prazo recomendado.\u003c\/li\u003e\n      \u003cli\u003eEm caso de resultado positivo, duvidoso ou contestado, solicite uma confirmação em laboratório.\u003c\/li\u003e\n    \u003c\/ul\u003e\n\n    \u003cp class=\"ama-bsafe-note\"\u003e\n      Um teste urinário rápido é uma ferramenta de rastreio e orientação. Não constitui por si só uma prova médico-legal definitiva. Para qualquer decisão médica, profissional ou jurídica, pode ser necessária uma confirmação por análise toxicológica.\n    \u003c\/p\u003e\n\n    \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e\n      \u003cp\u003e\n        \u003cstrong\u003eMenções legais :\u003c\/strong\u003e Este dispositivo médico é um produto de saúde regulamentado que, ao abrigo desta regulamentação, possui a marcação CE. Em caso de tratamento médico, resultado positivo, dúvida na interpretação ou situação de risco, consulte um profissional de saúde ou um laboratório de análises clínicas.\n      \u003c\/p\u003e\n    \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unidade","offer_id":56426435117380,"sku":"10413T-A-1","price":33.0,"currency_code":"USD","in_stock":true},{"title":"Conjunto de 5","offer_id":56426435150148,"sku":"10413T-A-1","price":164.0,"currency_code":"USD","in_stock":true},{"title":"Conjunto de 10","offer_id":56426435182916,"sku":"10413T-A-1","price":310.0,"currency_code":"USD","in_stock":true},{"title":"Conjunto de 25","offer_id":56426435215684,"sku":"10413T-A-1","price":693.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/photo_produit_drugdiag_T_de_face_v2.png?v=1779373751","url":"https:\/\/ama-prevention.com\/pt-pt\/products\/teste-urinario-por-imersao-13-drogas","provider":"AMA Prévention ","version":"1.0","type":"link"}